the vaccine – Page 90 – Communicable Diseases Research

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

Original Article

Published on 2021-09-082022-11-01
Journal: The New England Journal of Medicine [Category] COVID-19, Fulltext, MERS,

[키워드] 95% CI 95% confidence interval acute respiratory syndrome Ad26.COV2.S vaccine adjusted Admission Adults affected age ambulatory black BNT162b2 Care center circulation clinics conducted Control coronavirus coronavirus disease effective Effectiveness Electronic health record Hispanic hospital Hospitalization ICU ICU admission immunization Infection Inpatient intensive care laboratory-confirmed SARS-CoV-2 infection Local Medical conditions Messenger RNA molecular mRNA mRNA-1273 vaccine Older Patient patients Population Positive test ranged Result SARS-CoV-2 SARS-COV-2 infection second dose setting symptomatic the United State the vaccine vaccination Vaccine virus
[DOI] 10.1056/NEJMoa2110362 PMC 바로가기 [Article Type] Original Article

COVID-19 vaccines and mental distress

Research Article

Published on 2021-09-082022-10-28
Journal: PLoS ONE [Category] COVID-19, SARS,

Synthetic SARS-CoV-2 Spike-Based DNA Vaccine Elicits Robust and Long-Lasting Th1 Humoral and Cellular Immunity in Mice

Microbiology

Published on 2021-09-072022-10-31
Journal: Frontiers in Microbiology [Category] COVID-19,

[키워드] BALB/c BALB/c mice binding candidate vaccine CD4 CD8 Cell cellular immunity clinical testing coding sequence Consensus coronavirus disease COVID-19 cytokine production demonstrated DNA DNA vaccine dose effective elicit elicited ENhance full-length S global pandemic glycoprotein humoral IFN-γ IgG IgG antibodies IgG antibody IL-2 immune response immune responses immunization immunogenic in viral induce injection intramuscular long-lasting Measures memory memory T mice mouse model NAb neutralizing antibody Pathogenesis plasmid DNA preclinical (in vivo) studies Prophylactic Protective protective immunity Protein response robust Safe SARS-CoV-2 significant level significantly spike (S) glycoprotein synthetic T cell Th1 the vaccine therapeutic TNF Vaccine was tested
[DOI] 10.3389/fmicb.2021.727455 PMC 바로가기 [Article Type] Microbiology

RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates

Article

Published on 2021-09-072022-10-04
Journal: Cell Discovery [Category] 변종, 치료기술,

Optimal Reopening Pathways With COVID-19 Vaccine Rollout and Emerging Variants of Concern

COVID-19 백신 롤아웃 및 우려의 새로운 변종으로 최적의 재개방 경로

Public Health

Published on 2021-09-072022-09-11
Journal: Frontiers in Public Health [Category] MERS, SARS, 변종,

COVID-19 Morbidity and Mortality in Social Networks: Does It Influence Vaccine Hesitancy?

Brief Report

Published on 2021-09-072022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, SARS,

Willingness and SARS-CoV-2 Vaccination Coverage among Healthcare Workers in China: A Nationwide Study

Article

Published on 2021-09-062022-10-28
Journal: Vaccines [Category] COVID-19,

Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report

Case Report

Published on 2021-09-062022-10-28
Journal: Annals of Medicine and Surgery [Category] COVID-19,

Factors and Determinants for Uptake of COVID-19 Vaccine in a Medical University in Riyadh, Saudi Arabia

Family/General Practice

Published on 2021-09-062022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] acute respiratory syndrome affected age Antiviral treatment approved caused college coronavirus coronavirus disease Coronavirus-2 COVID-19 COVID-19 infection COVID-19 vaccine cross-sectional death demographic data determinant Factor factors and determinants female females Health immunization Infection Infectious disease Intervention ksau-hs majority male Medicine MOST Novel coronavirus participant predictor Prevent public health questionnaire Result SARS-CoV-2 Saudi Arabia Spread statistical significance statistically significant the vaccine thought university uptake vaccination Vaccines
[DOI] 10.7759/cureus.17768 PMC 바로가기 [Article Type] Family/General Practice

Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines

Review

Published on 2021-09-062022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] Nicotiana benthamaiana affected approach candidate Candidates clinical trial clinical trials convalescent coronavirus coronavirus disease COVID-19 COVID-19 vaccine COVID-19 vaccine development CoVLP CoVLP vaccine current demonstrated development diagnosing Ebola effective Effective vaccines Efficacy effort encapsulate Gaucher Disease glycoengineering immunization infectious disease outbreak Interim monoclonal antibody Neutralizing antibody response outbreak pandemic plant-based vaccine plants plasma preclinical study Prevalence RBD Safe SARS-CoV-2 SARS-CoV-2 variant Spike protein Spread status Strategy Subunit vaccine the vaccine transmission rate VLP ZMapp
[DOI] 10.3390/vaccines9090992 PMC 바로가기 [Article Type] Review